Deborah P Luxenberg

Title: Innovations and Contributions of Deborah P Luxenberg

Introduction

Deborah P Luxenberg is a notable inventor based in Melrose, MA (US), recognized for her significant contributions to the field of immunology. With a total of six patents to her name, she has made remarkable advancements in the development of therapeutic antibodies.

Latest Patents

Among her latest patents is a method involving the use of antibodies against human IL-22. This application provides human antibodies and antigen-binding fragments that specifically bind to human interleukin-22 (IL-22). These antibodies are instrumental in diagnosing, treating, or preventing various inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. Another significant patent involves nucleic acids encoding antibodies against PD-1 (Programmed Death 1). This disclosure presents antibodies and antigen-binding fragments that can act as agonists and/or antagonists of PD-1, thereby modulating immune responses. The compositions and methods disclosed may be utilized in treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer, and other immune system disorders.

Career Highlights

Throughout her career, Deborah has worked with prominent companies such as Wyeth and MedImmune Limited. Her work in these organizations has contributed to the advancement of therapeutic solutions in the medical field.

Collaborations

Deborah has collaborated with esteemed colleagues, including Mary Collins and Clive R Wood, further enhancing her research and development efforts.

Conclusion

Deborah P Luxenberg's innovative work in the field of immunology and her numerous patents highlight her significant impact on medical science. Her contributions continue to pave the way for advancements in the treatment of various immune-related disorders.